{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:09:49Z","timestamp":1790114989384,"version":"4.0.1"},"reference-count":153,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bja.2023.10.034","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T15:45:58Z","timestamp":1701186358000},"page":"53-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6875-8422","authenticated-orcid":false,"given":"Gladness D.","family":"Nethathe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-2072","authenticated-orcid":false,"given":"Peter J.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2023.10.034_bib1","first-page":"410","article-title":"Adjunctive corticosteroid treatment in septic shock","volume":"131","author":"Cohen","year":"2019","journal-title":"Anesthesiol J Am Soc Anesthesiol"},{"key":"10.1016\/j.bja.2023.10.034_bib2","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bja.2023.10.034_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2023.10.034_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bja.2023.10.034_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock","volume":"183","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.bja.2023.10.034_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMc1804993","article-title":"Glucocorticoids with or without fludrocortisone in septic shock","volume":"379","author":"Venkatesh","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bja.2023.10.034_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"COIITSS Study Investigators, Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2023.10.034_bib8","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1002\/ams2.563","article-title":"Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta-analysis","volume":"7","author":"Yamamoto","year":"2020","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.bja.2023.10.034_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmj.310.6980.656","article-title":"The mineralocorticoid effects of high dose hydrocortisone","volume":"310","author":"Ramsahoye","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2023.10.034_bib10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bja.2023.10.034_bib11","article-title":"The hypothalamus-pituitary-adrenal axis in sepsis- and hyperinflammation-induced critical illness: gaps in current knowledge and future translational research directions","volume":"84","author":"Berghe","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.bja.2023.10.034_bib12","doi-asserted-by":"crossref","first-page":"i1585","DOI":"10.1136\/bmj.i1585","article-title":"Sepsis: pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2023.10.034_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.pcl.2008.02.009","article-title":"Immunoparalysis and adverse outcomes from critical illness","volume":"55","author":"Frazier","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.bja.2023.10.034_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/AIA.0000000000000220","article-title":"Steroids and sepsis: the debate continues","volume":"57","author":"Ramanan","year":"2019","journal-title":"Int Anesthesiol Clin"},{"key":"10.1016\/j.bja.2023.10.034_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-015-0802-3","article-title":"Angiotensin II in septic shock","volume":"19","author":"Corr\u00eaa","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.bja.2023.10.034_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/SHK.0000000000000807","article-title":"Angiotensin II in refractory septic shock","volume":"47","author":"Antonucci","year":"2017","journal-title":"Shock"},{"key":"10.1016\/j.bja.2023.10.034_bib17","series-title":"Physiology, renin angiotensin system, StatPearls. Treasure Island","author":"Fountain","year":"2020"},{"key":"10.1016\/j.bja.2023.10.034_bib18","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.2174\/092986711796642562","article-title":"Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome","volume":"18","author":"Kaparianos","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bja.2023.10.034_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic renin-angiotensin systems in the critically ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.bja.2023.10.034_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.667254","article-title":"The role of renin-angiotensin-aldosterone system in the heart and lung: focus on COVID-19","volume":"12","author":"Mascolo","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bja.2023.10.034_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fendo.2013.00166","article-title":"New frontiers in the intrarenal renin-angiotensin system: a critical review of classical and new paradigms","volume":"4","author":"Zhuo","year":"2013","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","article-title":"Angiotensin-(1\u20137)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.bja.2023.10.034_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","article-title":"Vascular actions of aldosterone","volume":"50","author":"Briet","year":"2013","journal-title":"J\u00a0Vasc Res"},{"key":"10.1016\/j.bja.2023.10.034_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jss.2012.05.018","article-title":"Mineralocorticoid deficiency in hemorrhagic shock","volume":"180","author":"Tolstoy","year":"2013","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.bja.2023.10.034_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13054-022-04224-5","article-title":"Corticotropin-stimulated steroid profiles to predict shock development and mortality in sepsis: from the HYPRESS study","volume":"26","author":"Briegel","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.bja.2023.10.034_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.17085\/apm.20089","article-title":"Perioperative glucocorticoid management based on current evidence","volume":"16","author":"Seo","year":"2021","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.bja.2023.10.034_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/2042018818821294","article-title":"Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency","volume":"10","author":"Oprea","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib28","doi-asserted-by":"crossref","first-page":"bvaa145","DOI":"10.1210\/jendso\/bvaa145","article-title":"Empiric determination of the daily glucocorticoid replacement dose in adrenal insufficiency","volume":"4","author":"Caetano","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.bja.2023.10.034_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib30","series-title":"Aldosterone and mineralocorticoid receptors: renal and extrarenal roles, brenner and rector\u2019s the kidney","first-page":"335","author":"Pearce","year":"2020"},{"key":"10.1016\/j.bja.2023.10.034_bib31","series-title":"The adrenal glands, Textbook of endocrine physiology","author":"Auchus","year":"2011"},{"key":"10.1016\/j.bja.2023.10.034_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1172-5-9","article-title":"Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism","volume":"5","author":"Amar","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bja.2023.10.034_bib33","series-title":"Reproductive, maternal, newborn, and child health: disease control priorities, third edition (volume 2)","author":"Black","year":"2016"},{"key":"10.1016\/j.bja.2023.10.034_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/jc.2017-01928","article-title":"Primary adrenal insufficiency: managing mineralocorticoid replacement therapy","volume":"103","author":"Esposito","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib35","series-title":"Fludrocortisone, StatPearls. Treasure Island","author":"Rahman","year":"2022"},{"key":"10.1016\/j.bja.2023.10.034_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1739831","article-title":"Pediatric adrenal insufficiency: diagnosis, management, and new therapies","volume":"2018","author":"Bowden","year":"2018","journal-title":"Int J Pediatr"},{"key":"10.1016\/j.bja.2023.10.034_bib37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/adc.85.3.246","article-title":"Management of hyponatraemia in patients with acute cerebral insults","volume":"85","author":"Albanese","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bja.2023.10.034_bib38","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1530\/EJE-13-0450","article-title":"Therapy of endocrine disease: perspectives on the management of adrenal insufficiency: clinical insights from across Europe","volume":"169","author":"Grossman","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/ALN.0000000000003365","article-title":"Mineralocorticoid dysfunction during critical illness: a review of the evidence","volume":"133","author":"Nethathe","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.10.034_bib40","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","article-title":"50th anniversary of aldosterone","volume":"88","author":"Williams","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/eje.0.1510397","article-title":"Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties","volume":"151","author":"Grossmann","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/med.2610110604","article-title":"Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects","volume":"11","author":"Sutanto","year":"1991","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bja.2023.10.034_bib43","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/j.2040-4603.2014.tb00569.x","article-title":"The multifaceted mineralocorticoid receptor","volume":"4","author":"Gomez-Sanchez","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.bja.2023.10.034_bib44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.21037\/atm-21-5572","article-title":"CIRMI\u2014a new term for a concept worthy of further exploration: a narrative review","volume":"10","author":"Nethathe","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.bja.2023.10.034_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-016-9591-2","article-title":"Genomic and rapid effects of aldosterone: what we know and do not know thus far","volume":"22","author":"Hermidorff","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.bja.2023.10.034_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06017","article-title":"The new biology of aldosterone","volume":"186","author":"Connell","year":"2005","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.physiol.59.1.365","article-title":"Specific, nongenomic actions of steroid hormones","volume":"59","author":"Wehling","year":"1997","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bja.2023.10.034_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/nips.01596.2003","article-title":"Aldosterone: refreshing a slow hormone by swift action","volume":"19","author":"Boldyreff","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.bja.2023.10.034_bib49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0024-3205(02)01726-5","article-title":"The awakening cortisol response: no evidence for an influence of body posture","volume":"71","author":"Hucklebridge","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.bja.2023.10.034_bib50","unstructured":"Vernikos-Danellis J, Winget CM. The importance of light, postural and social cues in the regulation of the plasma cortisol rhythm in man 1979. Available from: http:\/\/ntrs.nasa.gov\/search.jsp?R=19790063385."},{"key":"10.1016\/j.bja.2023.10.034_bib51","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/HYPERTENSIONAHA.111.170977","article-title":"Is GPR30 the membrane aldosterone receptor postulated 20 years ago?","volume":"57","author":"Wendler","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.bja.2023.10.034_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.vh.2018.12.001","article-title":"Non-genomic effects of aldosterone, vitamins and hormones","volume":"109","author":"Mihailidou","year":"2019","journal-title":"Vitam Horm"},{"key":"10.1016\/j.bja.2023.10.034_bib53","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/HYPERTENSIONAHA.110.165076","article-title":"GPR30, mineralocorticoid receptors, and the rapid vascular effects of aldosterone","volume":"57","author":"Funder","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.bja.2023.10.034_bib54","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-pharmtox-010716-104651","article-title":"GPER (GPR30): a nongenomic receptor (GPCR) for steroid hormones with implications for cardiovascular disease and cancer","volume":"57","author":"Feldman","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bja.2023.10.034_bib55","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","article-title":"The nuclear receptor superfamily: a structural perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Sci Publ Protein Soc"},{"key":"10.1016\/j.bja.2023.10.034_bib56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/JME-08-0093","article-title":"Structure\u2013function relationships in the mineralocorticoid receptor","volume":"41","author":"Pippal","year":"2008","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib57","series-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects","article-title":"Glucocorticoid and mineralocorticoid receptors as transcription factors","author":"Eberwine","year":"1999"},{"key":"10.1016\/j.bja.2023.10.034_bib58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bja.2023.10.034_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/1043-2760(90)90026-Y","article-title":"Target tissue specificity of mineralocorticoids","volume":"1","author":"Funder","year":"1990","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bja.2023.10.034_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1113\/expphysiol.2008.045914","article-title":"The mammalian mineralocorticoid receptor: tying down a promiscuous receptor: mineralocorticoid receptor selectivity","volume":"95","author":"Gomez-Sanchez","year":"2010","journal-title":"Exp Physiol"},{"key":"10.1016\/j.bja.2023.10.034_bib62","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1210\/jc.2002-020970","article-title":"11\u03b2-Hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids","volume":"87","author":"Diederich","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib63","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s00134-007-0727-7","article-title":"Evidence of altered cortisol metabolism in critically ill patients: a prospective study","volume":"33","author":"Venkatesh","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bja.2023.10.034_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MED.0000000000000066","article-title":"Cortisol metabolism in critical illness: implications for clinical care","volume":"21","author":"Boonen","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.bja.2023.10.034_bib65","series-title":"South Dartmouth (MA)","article-title":"Glucocorticoid Receptor, Endotext","author":"Nicolaides","year":"2000"},{"key":"10.1016\/j.bja.2023.10.034_bib66","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","article-title":"A\u00a0general introduction to glucocorticoid biology","volume":"10","author":"Timmermans","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bja.2023.10.034_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.18773\/austprescr.1996.048","article-title":"Experimental and clinical pharmacology: corticosteroids - mechanisms of action","volume":"16","author":"Funder","year":"1996","journal-title":"Aust Prescr"},{"key":"10.1016\/j.bja.2023.10.034_bib68","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1046\/j.1523-1755.2000.00959.x","article-title":"Specificity in mineralocorticoid versus glucocorticoid action","volume":"57","author":"Fuller","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.bja.2023.10.034_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1098\/rsif.2011.0183","article-title":"System among the corticosteroids: specificity and molecular dynamics","volume":"9","author":"Brookes","year":"2012","journal-title":"J\u00a0R Soc Interface"},{"key":"10.1016\/j.bja.2023.10.034_bib70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/frne.1996.0143","article-title":"11\u03b2-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?","volume":"18","author":"Seckl","year":"1997","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib71","doi-asserted-by":"crossref","first-page":"E1122","DOI":"10.1152\/ajpendo.2001.281.6.E1122","article-title":"Nontraditional aspects of aldosterone physiology","volume":"281","author":"Ngarmukos","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib72","series-title":"Evidence-Based Practice of Critical Care","first-page":"521","article-title":"Is there a mineralocorticoid deficiency in critically ill patients? How can it be diagnosed? Should it be treated?","author":"Annane","year":"2010"},{"key":"10.1016\/j.bja.2023.10.034_bib73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.ph.55.030193.000555","article-title":"Aldosterone action","volume":"55","author":"Funder","year":"1993","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bja.2023.10.034_bib74","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1995.2464","article-title":"Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping","volume":"215","author":"Trapp","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bja.2023.10.034_bib75","series-title":"Steroid Analysis","first-page":"1","article-title":"The structure and nomenclature of steroids","author":"Kirk","year":"1995"},{"key":"10.1016\/j.bja.2023.10.034_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1530\/JOE-11-0178","article-title":"The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function","volume":"211","author":"Vinson","year":"2011","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mce.2003.10.041","article-title":"Molecular mechanism of activation and nuclear translocation of the mineralocorticoid receptor upon binding of pregnanesteroids","volume":"217","author":"Galigniana","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib78","doi-asserted-by":"crossref","first-page":"F699","DOI":"10.1152\/ajprenal.00133.2002","article-title":"Aldosterone inhibits HCO3- absorption via a nongenomic pathway in medullary thick ascending limb","volume":"283","author":"Good","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bja.2023.10.034_bib79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure","volume":"93","author":"Qin","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.bja.2023.10.034_bib80","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1161\/CIRCHEARTFAILURE.109.868513","article-title":"Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress","volume":"2","author":"Yamaji","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.bja.2023.10.034_bib81","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/ijms18051032","article-title":"Aldosterone and mineralocorticoid receptors\u2014physiology and pathophysiology","volume":"18","author":"Funder","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bja.2023.10.034_bib82","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.bja.2023.10.034_bib83","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.107.098012","article-title":"Mineralocorticoid receptor activation and oxidative stress","volume":"50","author":"Funder","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.bja.2023.10.034_bib84","series-title":"30th Annual Meeting of the International Aldosterone Conference","article-title":"Agonist\/antagonist activity of cortisol in cardiomyocyte mineralocorticoid receptors is determined by redox state","author":"Mihailidou","year":"2004"},{"key":"10.1016\/j.bja.2023.10.034_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/JOE-11-0372","article-title":"Mechanisms of ligand specificity of the mineralocorticoid receptor","volume":"213","author":"Fuller","year":"2012","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib86","series-title":"Annual Reports on NMR Spectroscopy","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/bs.arnmr.2017.08.002","article-title":"Chapter five \u2013 progress in our understanding of 19F chemical shifts","volume":"93","author":"Dahanayake","year":"2018"},{"key":"10.1016\/j.bja.2023.10.034_bib87","series-title":"Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals","first-page":"281","article-title":"Microbial metabolism of fluorinated drugs","author":"Murphy","year":"2019"},{"key":"10.1016\/j.bja.2023.10.034_bib88","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1021\/cr068203e","article-title":"Synthesis and pharmacology of anti-inflammatory steroidal antedrugs","volume":"108","author":"Khan","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bja.2023.10.034_bib89","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.1903172116","article-title":"Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist","volume":"116","author":"Fuller","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bja.2023.10.034_bib90","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/en.2014-1048","article-title":"From receptor balance to rational glucocorticoid therapy","volume":"155","author":"De Kloet","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.bja.2023.10.034_bib91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.vh.2018.09.004","article-title":"Mechanisms of mineralocorticoid receptor signaling","volume":"109","author":"Fuller","year":"2019","journal-title":"Vitam Horm"},{"key":"10.1016\/j.bja.2023.10.034_bib92","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.psyneuen.2014.10.022","article-title":"The brain mineralocorticoid receptor and stress resilience","volume":"52","author":"Heegde","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bja.2023.10.034_bib93","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fendo.2020.00347","article-title":"Glucocorticoid signaling and the aging heart","volume":"11","author":"Cruz-Topete","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib94","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.bja.2023.10.034_bib95","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000181808","article-title":"Renal 11-beta-hydroxysteroid dehydrogenase: a mechanism ensuring mineralocorticoid specificity","volume":"34","author":"Edwards","year":"1990","journal-title":"Horm Res"},{"key":"10.1016\/j.bja.2023.10.034_bib96","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1681\/ASN.2016020124","article-title":"Coordinated control of ENaC and Na+ ,K\u00a0+ -ATPase in renal collecting duct","volume":"27","author":"Feraille","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.bja.2023.10.034_bib97","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1085\/jgp.20028559","article-title":"Effects of aldosterone on biosynthesis, traffic, and functional expression of epithelial sodium channels in A6 cells","volume":"119","author":"Rosa","year":"2002","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.bja.2023.10.034_bib98","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.96.5.2514","article-title":"Epithelial sodium channel regulated by aldosterone-induced protein sgk","volume":"96","author":"Chen","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bja.2023.10.034_bib99","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1096\/fj.201902254RR","article-title":"Aldosterone-induced microRNAs act as feedback regulators of mineralocorticoid receptor signaling in kidney epithelia","volume":"34","author":"Ozbaki-Yagan","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.bja.2023.10.034_bib100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000070245","article-title":"SGK1 regulation of epithelial sodium transport","volume":"13","author":"Pearce","year":"2003","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.bja.2023.10.034_bib101","article-title":"Neuroimmune regulation in sepsis-associated encephalopathy: the interaction between the brain and peripheral immunity","volume":"13","author":"Liu","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.bja.2023.10.034_bib102","doi-asserted-by":"crossref","first-page":"bqaa242","DOI":"10.1210\/endocr\/bqaa242","article-title":"Glucocorticoids and the brain after critical illness","volume":"162","author":"Hill","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.bja.2023.10.034_bib103","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.3390\/ijerph17165852","article-title":"Sepsis-associated brain dysfunction: a review of current literature","volume":"17","author":"Czempik","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.bja.2023.10.034_bib104","article-title":"Stress-induced neuroinflammation of the spinal cord is restrained by Cort113176 (Dazucorilant), a specific glucocorticoid receptor modulator","author":"Meyer","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.bja.2023.10.034_bib105","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3390\/ijms21062137","article-title":"Insights into the therapeutic potential of glucocorticoid receptor modulators for neurodegenerative diseases","volume":"21","author":"De Nicola","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bja.2023.10.034_bib106","doi-asserted-by":"crossref","first-page":"F559","DOI":"10.1152\/ajprenal.90399.2008","article-title":"Aldosterone in the brain","volume":"297","author":"Geerling","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bja.2023.10.034_bib107","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2009.10.017","article-title":"The role of 11\u03b2-hydroxysteroid dehydrogenase type 2 in human hypertension","volume":"1802","author":"Ferrari","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bja.2023.10.034_bib108","doi-asserted-by":"crossref","first-page":"24248","DOI":"10.1016\/S0021-9258(18)35757-0","article-title":"Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone","volume":"267","author":"Ueda","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bja.2023.10.034_bib109","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yfrne.2018.02.003","article-title":"Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation","volume":"49","author":"De Kloet","year":"2018","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000227807","article-title":"Central mineralocorticoid receptors and cardiovascular disease","volume":"90","author":"Gomez Sanchez","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bja.2023.10.034_bib111","series-title":"Aldosterone-Mineralocorticoid Receptor - Cell Biology to Translational Medicine","article-title":"MR\/GR signaling in the brain during the stress response","author":"De Kloet","year":"2019"},{"key":"10.1016\/j.bja.2023.10.034_bib112","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"De Kloet","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bja.2023.10.034_bib113","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1124\/pr.112.005892","article-title":"Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes","volume":"64","author":"Jo\u00ebls","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bja.2023.10.034_bib114","doi-asserted-by":"crossref","first-page":"E649","DOI":"10.1152\/ajpendo.1990.258.4.E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib115","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1161\/CIRCULATIONAHA.115.019341","article-title":"Conditional deletion of Hsd11b2 in the brain causes salt appetite and hypertension","volume":"133","author":"Evans","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bja.2023.10.034_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.694758","article-title":"The cardiac mineralocorticoid receptor (MR): a therapeutic target against ventricular arrhythmias","volume":"12","author":"Rossier","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib117","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1210\/en.2009-1375","article-title":"Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes","volume":"151","author":"Rossier","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bja.2023.10.034_bib118","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/jm00357a021","article-title":"Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives","volume":"26","author":"Seamon","year":"1983","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.bja.2023.10.034_bib119","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/en.2003-1137","article-title":"Rapid, nongenomic effects of aldosterone in the heart mediated by \u03b5 protein kinase C","volume":"145","author":"Mihailidou","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bja.2023.10.034_bib120","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1210\/endo.138.8.5352","article-title":"Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in\u00a0vitro","volume":"138","author":"Sato","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bja.2023.10.034_bib121","first-page":"384","article-title":"Balancing stress signalling in the heart","volume":"16","author":"Fern\u00e1ndez-Ruiz","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.bja.2023.10.034_bib122","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau9685","article-title":"Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice","volume":"12","author":"Oakley","year":"2019","journal-title":"Sci Signal"},{"key":"10.1016\/j.bja.2023.10.034_bib123","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0024-3205(81)90090-4","article-title":"Adrenal steroids and extinction behavior: antagonism by progesterone, deoxycorticosterone and dexamethasone of a specific effect of corticosterone","volume":"28","author":"Bohus","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.bja.2023.10.034_bib124","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(83)90834-X","article-title":"Aldosterone blocks the response to corticosterone in the raphe-hippocampal serotonin system","volume":"264","author":"De Kloet","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.bja.2023.10.034_bib125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0018-506X(83)90009-0","article-title":"Antagonistic effects of aldosterone on corticosterone-mediated changes in exploratory behavior of adrenalectomized rats","volume":"17","author":"Veldhuis","year":"1983","journal-title":"Horm Behav"},{"key":"10.1016\/j.bja.2023.10.034_bib126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3810\/pgm.2009.01.1949","article-title":"The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?","volume":"121","author":"Holtorf","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1016\/j.bja.2023.10.034_bib127","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1210\/jc.2016-1271","article-title":"Compounded bioidentical hormones in endocrinology practice: an Endocrine Society scientific statement","volume":"101","author":"Santoro","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bja.2023.10.034_bib128","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1749-6632.1955.tb42514.x","article-title":"Comparative action of aldosterone and 9-alpha-fluorohydrocortisone in man","volume":"61","author":"Thorn","year":"1955","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bja.2023.10.034_bib129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4065\/mcp.2010.0714","article-title":"Bioidentical hormone therapy","volume":"86","author":"Files","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bja.2023.10.034_bib130","first-page":"16","article-title":"Defining bioidentical hormones for menopause-related symptoms","volume":"9","author":"Whelan","year":"2011","journal-title":"Pharm Pract Internet"},{"key":"10.1016\/j.bja.2023.10.034_bib131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/10253899709014734","article-title":"Why dexamethasone poorly penetrates in brain","volume":"2","author":"De Kloet","year":"1997","journal-title":"Stress"},{"key":"10.1016\/j.bja.2023.10.034_bib132","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/endo.139.4.5917","article-title":"Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice","volume":"139","author":"Meijer","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bja.2023.10.034_bib133","article-title":"The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone","volume":"20","author":"Bamberg","year":"2019","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.bja.2023.10.034_bib134","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bja.2023.10.034_bib135","unstructured":"PubChem. Fludrocortisone. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/31378 [Accessed 21 July 2020]."},{"key":"10.1016\/j.bja.2023.10.034_bib136","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A\u00a0practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.bja.2023.10.034_bib137","series-title":"Primer on the Autonomic Nervous System","first-page":"635","article-title":"Fludrocortisone","author":"Robertson","year":"2012"},{"key":"10.1016\/j.bja.2023.10.034_bib138","series-title":"Comprehensive Chirality","first-page":"70","article-title":"Fluorine in medicinal chemistry: importance of chirality","author":"Tredwell","year":"2012"},{"key":"10.1016\/j.bja.2023.10.034_bib139","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0039-128X(94)90074-4","article-title":"A\u00a0sensitive radioimmunoassay for fludrocortisone in human plasma","volume":"59","author":"Mitsky","year":"1994","journal-title":"Steroids"},{"key":"10.1016\/j.bja.2023.10.034_bib140","series-title":"Analytical Profiles of Drug Substances","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0099-5428(08)60071-4","article-title":"Fludrocortisone acetate","author":"Florey","year":"1974"},{"key":"10.1016\/j.bja.2023.10.034_bib141","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1172\/JCI110024","article-title":"Effects of corticosteroids on eosinophil chemotaxis and adherence","volume":"67","author":"Altman","year":"1981","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bja.2023.10.034_bib142","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.2009.815","article-title":"Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review","volume":"301","author":"Annane","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2023.10.034_bib143","series-title":"Fludrocortisone. xPharm: the comprehensive pharmacology reference","first-page":"1","author":"Furman","year":"2007"},{"key":"10.1016\/j.bja.2023.10.034_bib144","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJM199407283310408","article-title":"Disorders of aldosterone biosynthesis and action","volume":"331","author":"White","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bja.2023.10.034_bib145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fendo.2017.00101","article-title":"Editorial: ACTH action in the adrenal cortex: from molecular biology to pathophysiology","volume":"8","author":"Gallo-Payet","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib146","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mce.2016.10.014","article-title":"Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism","volume":"441","author":"Nishimoto","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bja.2023.10.034_bib147","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fnins.2016.00238","article-title":"Functional zonation of the adult mammalian adrenal cortex","volume":"10","author":"Vinson","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.bja.2023.10.034_bib148","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bja.2023.10.034_bib149","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1369\/0022155411404071","article-title":"Alteration of subcapsular adrenocortical zonation in humans with aging: the progenitor zone predominates over the previously well-developed zona glomerulosa after 40 years of age","volume":"59","author":"Aiba","year":"2011","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.bja.2023.10.034_bib150","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab048.139","article-title":"Human adrenal cortical zone changes with aging","volume":"5","author":"Tezuka","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.bja.2023.10.034_bib151","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/bcp.13065","article-title":"Pharmacokinetics of oral fludrocortisone in septic shock","volume":"82","author":"Polito","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bja.2023.10.034_bib152","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/bcp.13562","article-title":"Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator","volume":"84","author":"Erlandsson","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bja.2023.10.034_bib153","first-page":"234","article-title":"Clinician preferences for prescription of corticosteroids in patients with septic shock: an international survey","volume":"23","author":"Hammond","year":"2021","journal-title":"Crit Care Resusc"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091223005895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091223005895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:17:37Z","timestamp":1762103857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091223005895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0007091223005895"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2023.10.034","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2023.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}